| scholarly article | Q13442814 |
| P50 | author | Joel Gelernter | Q30032479 |
| Lindsay A. Farrer | Q37380266 | ||
| Henry R. Kranzler | Q67465892 | ||
| Albert J Arias | Q92803028 | ||
| Amira Pierucci-Lagha | Q114515329 | ||
| P2093 | author name string | Joseph F Cubells | |
| Grace Chan | |||
| P2860 | cites work | Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative | Q34324588 |
| Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue? | Q34560142 | ||
| Genomewide linkage scan for opioid dependence and related traits | Q34658100 | ||
| How treatments for pathological gambling can be informed by treatments for substance use disorders | Q34861212 | ||
| Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues | Q35738078 | ||
| The cannabis withdrawal syndrome | Q36448206 | ||
| Cannabis withdrawal among non-treatment-seeking adult cannabis users | Q39355645 | ||
| A new, semi-structured psychiatric interview for use in genetic linkage studies: a report on the reliability of the SSAGA. | Q40755655 | ||
| Clinical implications for four drugs of the DSM-IV distinction between substance dependence with and without a physiological component. | Q46002563 | ||
| Diagnostic reliability of the Semi-structured Assessment for Drug Dependence and Alcoholism (SSADDA). | Q46493166 | ||
| Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia | Q46503427 | ||
| Concordance of DSM-IV alcohol and drug use disorder criteria and diagnoses as measured by AUDADIS-ADR, CIDI and SCAN. | Q47778132 | ||
| Comparing assessments of DSM-IV substance dependence disorders using CIDI-SAM and SCAN. | Q51567259 | ||
| Physiological alcohol dependence as a "specifier" of risk for medical problems and relapse liability in DSM-IV. | Q52261733 | ||
| Substance Dependence Severity Scale (SDSS): reliability and validity of a clinician-administered interview for DSM-IV substance use disorders. | Q54255884 | ||
| Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior | Q71025512 | ||
| Reliability of individual diagnostic criterion items for psychoactive substance dependence and the impact on diagnosis | Q71518759 | ||
| P433 | issue | 1 | |
| P921 | main subject | alcoholism | Q15326 |
| substance dependence | Q3378593 | ||
| drug dependence | Q3541786 | ||
| P304 | page(s) | 85-90 | |
| P577 | publication date | 2007-06-27 | |
| P1433 | published in | Drug and Alcohol Dependence | Q5308875 |
| P1476 | title | Reliability of DSM-IV diagnostic criteria using the semi-structured assessment for drug dependence and alcoholism (SSADDA). | |
| P478 | volume | 91 |
| Q35058887 | 5-HTTLPR as a potential moderator of the effects of adverse childhood experiences on risk of antisocial personality disorder |
| Q35581507 | A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women |
| Q34544441 | A complex interplay between personality domains, marital status and a variant in CHRNA5 on the risks of cocaine, nicotine dependences and cocaine-induced paranoia |
| Q93141972 | A genome-wide association study of cocaine use disorder accounting for phenotypic heterogeneity and gene–environment interaction |
| Q38436206 | A genome-wide gene-by-trauma interaction study of alcohol misuse in two independent cohorts identifies PRKG1 as a risk locus |
| Q91329623 | A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans |
| Q33653144 | Adolescent cannabis use increases risk for cocaine-induced paranoia |
| Q37392330 | Adverse childhood events as risk factors for substance dependence: partial mediation by mood and anxiety disorders |
| Q35017248 | Agitated depression in substance dependence |
| Q35866698 | An Effective Method to Identify Heritable Components from Multivariate Phenotypes |
| Q33553106 | Assessing addiction: concepts and instruments |
| Q36544301 | Association of COL25A1 with comorbid antisocial personality disorder and substance dependence |
| Q24289310 | Association of gamma-aminobutyric acid A receptor α2 gene (GABRA2) with alcohol use disorder |
| Q37410610 | Association of markers in the 3' region of the GluR5 kainate receptor subunit gene to alcohol dependence |
| Q37349982 | Association of psychiatric and substance use disorder comorbidity with cocaine dependence severity and treatment utilization in cocaine-dependent individuals |
| Q37577241 | Autosomal linkage scan for loci predisposing to comorbid dependence on multiple substances |
| Q37729012 | Characteristics and course of dependence in cocaine-dependent individuals who never used alcohol or marijuana or used cocaine first. |
| Q93097750 | Characterization of DSM-IV Opioid Dependence Among Individuals of European Ancestry |
| Q35679921 | Childhood adversity increases risk for nicotine dependence and interacts with α5 nicotinic acetylcholine receptor genotype specifically in males |
| Q33599863 | Clinical features of methamphetamine-induced paranoia and preliminary genetic association with DBH-1021C→T in a Thai treatment cohort |
| Q33967660 | Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use. |
| Q34124348 | Comparing the utility of homogeneous subtypes of cocaine use and related behaviors with DSM-IV cocaine dependence as traits for genetic association analysis |
| Q33938928 | Critical evaluation of transcription factor Atf2 as a candidate modulator of alcohol preference in mouse and human populations. |
| Q35635725 | DSM criteria for tobacco use disorder and tobacco withdrawal: a critique and proposed revisions for DSM-5. |
| Q30544314 | DSM-5 criteria for substance use disorders: recommendations and rationale |
| Q33602582 | DSM-5 gambling disorder: prevalence and characteristics in a substance use disorder sample |
| Q42009133 | Deep resequencing of 17 glutamate system genes identifies rare variants in DISC1 and GRIN2B affecting risk of opioid dependence |
| Q37105862 | Dense genomewide linkage scan for alcohol dependence in African Americans: significant linkage on chromosome 10. |
| Q35188670 | Empirically derived subtypes of opioid use and related behaviors |
| Q37173657 | GABRA2 genotype, impulsivity, and body mass |
| Q92635298 | Genome-Wide Association Study of Opioid Cessation |
| Q28943284 | Genome-wide association study identifies new susceptibility loci for posttraumatic stress disorder |
| Q30303052 | Genome-wide association study of copy number variations (CNVs) with opioid dependence |
| Q40367486 | Genome-wide association study of therapeutic opioid dosing identifies a novel locus upstream of OPRM1. |
| Q91619689 | Genomewide Gene-by-Sex Interaction Scans Identify ADGRV1 for Sex Differences in Opioid Dependent African Americans |
| Q49822467 | Genomewide association study of alcohol dependence and related traits in a Thai population |
| Q34287000 | Haplotypic variants in DRD2, ANKK1, TTC12, and NCAM1 are associated with comorbid alcohol and drug dependence |
| Q34428665 | Identification of POMC exonic variants associated with substance dependence and body mass index |
| Q36091933 | Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors |
| Q64111996 | Increased Risk of Multiple Outpatient Surgeries in African-American Carriers of Transthyretin Val122Ile Mutation Is Modulated by Non-Coding Variants |
| Q59329750 | Inferring phenotypes from substance use via collaborative matrix completion |
| Q37369050 | Integrating GWASs and human protein interaction networks identifies a gene subnetwork underlying alcohol dependence |
| Q35875576 | Inter-observer reliability of DSM-5 substance use disorders |
| Q34311527 | Inter-rater reliability and concurrent validity of DSM-IV opioid dependence in a Hmong isolate using the Thai version of the Semi-Structured Assessment for Drug Dependence and Alcoholism (SSADDA). |
| Q34159604 | Interaction of FKBP5 with childhood adversity on risk for post-traumatic stress disorder |
| Q33840144 | Interactive effect of stressful life events and the serotonin transporter 5-HTTLPR genotype on posttraumatic stress disorder diagnosis in 2 independent populations |
| Q36975926 | Linkage analysis followed by association show NRG1 associated with cannabis dependence in African Americans |
| Q35189964 | Multi-view singular value decomposition for disease subtyping and genetic associations |
| Q41872179 | Multiview comodeling to improve subtyping and genetic association of complex diseases |
| Q53088889 | No association between ADCYAP1R1 and post-traumatic stress disorder in two independent samples. |
| Q37114924 | Ordered subset linkage analysis based on admixture proportion identifies new linkage evidence for alcohol dependence in African-Americans |
| Q38675485 | Oxytocin receptor gene polymorphisms, attachment, and PTSD: Results from the National Health and Resilience in Veterans Study |
| Q47412479 | Pattern of Methamphetamine Use and the Time Lag to Methamphetamine Dependence |
| Q37242360 | Posttraumatic mental health establishment of the Tsunami survivors in Thailand |
| Q100674272 | Predicting alcohol dependence from multi-site brain structural measures |
| Q46977031 | Prevalence and correlates of ADHD in individuals with substance use disorder in Nigeria |
| Q37055258 | Prevalence of DSM-IV and DSM-5 alcohol, cocaine, opioid, and cannabis use disorders in a largely substance dependent sample |
| Q33958030 | Pro-opiomelanocortin gene variation related to alcohol or drug dependence: evidence and replications across family- and population-based studies |
| Q35425270 | Rare nonsynonymous variants in alpha-4 nicotinic acetylcholine receptor gene protect against nicotine dependence |
| Q37375052 | Rate of progression from first use to dependence on cocaine or opioids: a cross-substance examination of associated demographic, psychiatric, and childhood risk factors |
| Q35785715 | Refining multivariate disease phenotypes for high chip heritability |
| Q91726009 | Risk Locus Identification Ties Alcohol Withdrawal Symptoms to SORCS2 |
| Q33842711 | S100A10 identified in a genome-wide gene × cannabis dependence interaction analysis of risky sexual behaviours |
| Q92369848 | Salivary microRNAs identified by small RNA sequencing and machine learning as potential biomarkers of alcohol dependence |
| Q36190394 | Serotonin transporter 5-HTTLPR genotype moderates the effects of childhood adversity on posttraumatic stress disorder risk: a replication study |
| Q39370565 | Sex Differences in Methamphetamine Use and Dependence in a Thai Treatment Center |
| Q37162719 | Sources of unreliability in the diagnosis of substance dependence. |
| Q36190402 | Substance dependence low-density whole genome association study in two distinct American populations |
| Q34307234 | Subtypes of major depression in substance dependence. |
| Q34240770 | The effects of a MAP2K5 microRNA target site SNP on risk for anxiety and depressive disorders |
| Q36934229 | The effects of child maltreatment on early signs of antisocial behavior: genetic moderation by tryptophan hydroxylase, serotonin transporter, and monoamine oxidase A genes |
| Q35651646 | The joint effects of ADH1B variants and childhood adversity on alcohol related phenotypes in African-American and European-American women and men |
| Q37526439 | The α-endomannosidase gene (MANEA) is associated with panic disorder and social anxiety disorder |
| Q33885716 | Transient cocaine-associated behavioral symptoms rated with a new instrument, the scale for assessment of positive symptoms for cocaine-induced psychosis (SAPS-CIP). |
| Q87817445 | VIGAN: Missing View Imputation with Generative Adversarial Networks |
| Q36906291 | Variation in OPRM1 and risk of suicidal behavior in drug-dependent individuals |
| Q34872888 | Variation in genes encoding the neuroactive steroid synthetic enzymes 5α-reductase type 1 and 3α-reductase type 2 is associated with alcohol dependence |
| Q36113070 | Which alcohol use disorder criteria contribute to the association of ADH1B with alcohol dependence? |
Search more.